UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2018

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT

 

For the transition period from N/A to N/A

 

Commission File No. 000-28745

 

Cipherloc Corporation

(Name of small business issuer as specified in its charter)

 

Texas   86-0837077
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)

 

825 Main St, Suite 100

Buda, TX 78610

(Address of principal executive offices)

 

(702) 818-9011

Registrant’s telephone number, including area code

 

Indicate by check mark whether the Registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days:

Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer [  ] Accelerated filer [  ]
  Non–Accelerated filer [  ] Smaller reporting company [X]
      Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act).

Yes [  ] No [X]

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at August 10, 2018
Common stock, $0.01 par value   40 ,133,664

 

 

 

     

 

 

CIPHERLOC CORPORATION

INDEX TO FORM 10-Q FILING

FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2018 AND 2017

TABLE OF CONTENTS

 

  PAGE
PART I - FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited) 3
  Balance Sheets 4
  Statements of Operations 5
  Statements of Cash Flows 6
  Statement of Stockholders’ Deficit 7
  Notes to Financial Statements 8
Item 2. Management Discussion & Analysis of Financial Condition and Results of Operations 13
Item 3 Quantitative and Qualitative Disclosures About Market Risk 16
Item 4. Controls and Procedures 16
     
PART II - OTHER INFORMATION  
   
Item 1. Legal Proceedings 18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18
Item 3. Defaults Upon Senior Securities 18
Item 4. Mining Safety Disclosures 18
Item 5 Other Information 18
Item 6. Exhibits 18
     
CERTIFICATIONS  
   
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act  
31.2 Certification of Acting Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act  
32.1 Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act  
32.2 Certification of Acting Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act  

 

  2  

 

 

PART I

FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders’ equity in conformity with accounting principles generally accepted in the United States of America. Except as disclosed herein, there has been no material change in the information disclosed in the notes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2017. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included, and all such adjustments are of a normal recurring nature. Operating results for the three and nine months ended June 30, 2018 are not necessarily indicative of the results that can be expected for the year ending September 30, 2018.

 

  3  

 

 

CIPHERLOC CORPORATION

BALANCE SHEETS

(UNAUDITED)

 

    June 30, 2018     September 30, 2017  
             
ASSETS                
Current Assets                
Cash   $ 10,230,369     $ 227,396  
Total Current Assets     10,230,369       227,396  
                 
Other assets     12,217       12,218  
Deferred offering costs     282,750        
Fixed assets, net     7,334       11,170  
Total Assets   $ 10,532,670     $ 250,784  
                 
LIABILITIES & STOCKHOLDERS’ DEFICIT                
Current Liabilities                
Accounts payable and accrued liabilities   $ 50,188     $ 59,763  
Accrued compensation     449,014       505,027  
Convertible notes payable, net of discount of $303,322           26,678  
Deferred revenue-current           308,412  
Total Current Liabilities     499,202       899,880  
                 
Long-Term Liabilities                
Common stock subscription deposit     2,262,000        
Deferred revenue, net of current portion           7,836  
Total Long-Term Liabilities     2,262,000       7,836  
Total Liabilities     2,761,202       907,716  
                 
Commitments and Contingencies (Note 5)                
                 
Series A Convertible Preferred stock, $0.01 par value, 10,000,000 shares authorized; 1,000,000 and 10,000,000 issued and outstanding as of June 30, 2018 and September 30, 2017, respectively     10,000       100,000  
Common stock, $0.01 par value, 650,000,000 shares authorized; 32,199,607 and 6,635,127 issued and outstanding as of June 30, 2018 and September 30, 2017, respectively     321,995       66,351  
Additional paid-in capital     60,371,474       49,378,447  
Accumulated deficit     (52,932,001 )     (50,201,730 )
Total Stockholders’ Deficit     7,771,468       (656,932 )
Total Liabilities and Stockholders’ Deficit   $ 10,532,670     $ 250,784  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

  4  

 

 

CIPHERLOC CORPORATION

STATEMENTS OF OPERATIONS

(UNAUDITED)

 

    Three Months Ended     Nine Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
Revenues   $ 87,477     $ 114,386     $ 316,248     $ 351,633  
Cost of revenues     13,424       30,300       89,230       90,900  
Gross Profit     74,053       84,086       227,018       260,733  
                                 
Operating Expenses                                
General and administrative (includes stock-based expense of $0 and $2,192,200 for the three and nine months ended June 30, 2017, respectively)     424,702       247,688       838,988       2,956,596  
Sales and marketing (includes stock-based expense of $31,250 and $93,748 for the three and nine months ended June 30, 2017, respectively)     74,271       35,466       119,433       188,950  
Research and development (includes stock-based expense of $37,046 and $204,789 for the three and nine months ended June 30, 2018, respectively, and $25,000 and $516,515 for the three and nine months ended June 30, 2017, respectively)     210,126       198,004       576,114       954,499  
Settlement expense                 81,000       106,250  
Total Operating Expenses     709,099       481,158       1,615,535       4,206,295  
Operating Loss     (635,046 )     (397,072 )     (1,388,517 )     (3,945,562 )
                                 
Other Expenses                                
Loss on extinguishment of convertible notes     (153,621 )           (317,268 )      
Excess fair value of derivatives in convertible note                 (486,745 )      
Change in fair value of derivatives     (1,794 )           (8,536 )      
Interest expense     (20,887 )     (11,790 )     (529,205 )     (34,488 )
Net Loss   $ (811,348 )   $ (408,862 )   $ (2,730,371 )   $ (3,980,050 )
                                 
Net Loss per Common Share – Basic and Diluted:   $ (0.03 )   $ (0.06 )   $ (0.16 )   $ (0.66 )
                                 
Weighted Average Common Shares Outstanding – Basic and Diluted     26,112,624       6,327,606       16,858,489       6,063,311  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

  5  

 

 

CIPHERLOC CORPORATION

STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

    Nine Months Ended  
    June 30,  
    2018     2017  
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss   $ (2,730,271 )   $ (3,980,050 )
Adjustments to reconcile net loss to net cash flows used in operating activities:                
Depreciation     3,836       4,143  
Stock-based compensation     204,788       2,807,172  
Stock issued for services     15,000        
Settlement expense     81,000        
Termination of software license           106,250  
Loss on extinguishment     317,268        
Debt discount amortization     491,132        
Excess fair value of derivatives in convertible note     486,745        
Change in fair value of derivatives     8,536        
Changes in operating assets and liabilities:                
Prepaid officer compensation           44,788  
Prepaid expenses and other assets           2,501  
Deferred revenue     (316,248 )     (351,633 )
Accounts payable and accrued liabilities     (65,588 )     (39,847 )
Net cash used in operating activities     (1,503,802 )     (1,406,676 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Purchase of fixed assets and software           (2,798 )
Net cash used in investing activities           (2,798 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Common stock issued for cash     10,009,925       1,186,720  
Common stock subscription deposit     2,262,000        
Deferred offering costs     (282,750 )      
Issuance of convertible note     242,600        
Repayment of convertible notes     (725,000 )      
Net cash provided by financing activities     11,506,775       1,186,720  
                 
DECREASE IN CASH     10,002,973       (222,754 )
CASH, BEGINNING OF PERIOD     227,396       344,138  
CASH, END OF PERIOD   $ 10,230,369     $ 121,384  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

  6  

 

 

CIPHERLOC CORPORATION

STATEMENT OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

 

    Preferred Stock     Common Stock     Additional Paid-in     Accumulated     Stockholders’  
    Shares     Amount     Shares     Amount     Capital     Deficit    

Deficit

 
Balance at September 30, 2017     10,000,000     $ 100,000       6,635,127     $ 66,351     $ 49,378,447     $ (50,201,730 )   $ (656,932 )
Common stock issued for cash                 11,407,400       114,074       9,895,851             10,009,925  
Common stock issued to officers and employees                 113,151       1,131       203,657             204,788  
Common stock issued for services                 10,000       100       14,900             15,000  
Common stock issued for legal settlement                 50,000       500       80,500             81,000  
Convertible notes – issuance of common stock                 362,500       3,625       498,875             502,500  
Convertible note – issuance of warrants                             90,345             90,345  
Convertible note – amendment of existing warrants                             74,041             74,041  
Settlement of convertible note                 121,429       1,214       179,858             181,072  
Related party conversion of preferred stock     (9,000,000 )     (90,000 )     13,500,000       135,000       (45,000 )            
Net loss                                   (2,730,271 )     (2,730,271 )

Balance at

June 30, 2018

    1,000,000     $ 10,000       32,199,607     $ 321,995     $ 60,371,474     $ (52,932,001 )   $ 7,771,468  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

  7  

 

 

CIPHERLOC CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2018 AND 2017

(Unaudited)

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

Cipherloc Corporation (the “Company”) was incorporated in Texas on June 22, 1953 as American Mortgage Company. On March 15, 2015, the Company changed its name to Cipherloc Corporation. The name change became effective by the Amended Certificate as of March 23, 2015.

 

Cipherloc is a data security solutions company. Our highly innovative, polymorphic encryption technology is designed to enable an iron-clad layer of protection to be added to existing solutions.

 

NOTE 2 - BASIS OF PRESENTATION OF INTERIM FINANCIAL STATEMENTS

 

The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America. The accompanying interim unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In our opinion, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

 

Operating results for the three and nine months ended June 30, 2018 are not necessarily indicative of the results that may be expected for the year ending September 30, 2018. Notes to the unaudited interim financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended September 30, 2017 have been omitted; this report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended September 30, 2017 included within the Company’s Form 10-K as filed with the Securities and Exchange Commission.

 

NOTE 3  - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America. Significant accounting policies are as follows:

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At June 30, 2018 and September 30, 2017, cash and cash equivalents include cash on hand and cash in the bank. The Company maintains its cash in accounts held by large, globally recognized banks which, at times, may exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation (FDIC). The FDIC insures these deposits up to $250,000. At June 30, 2018, $9,980,369 of the Company’s cash balance was uninsured, and at September 30, 2017, none of its cash balance was uninsured. The Company has not experienced any losses in such accounts.

 

Risks and Uncertainties

 

The Company’s continued existence is dependent upon sufficient capital to explore potential strategic relationships, complete development and marketing of the Company’s technologies, and operate the business. The Company raised $10,009,925 through the issuance of investment units, each consisting of one share of common stock and one warrant to purchase one additional share of common stock for $1.20 within five years (“Units”), during the nine months ended June 30, 2018, and it intends to continue raising money through a private placement memorandum. Management used $725,000 of the proceeds from this financing to repay its two convertible notes.

 

The Company has yet to establish profitable operations and has an accumulated deficit at June 30, 2018 of $52,932,001. It also has negative operating cash flows. These adverse conditions could affect the Company’s financial condition and its results of operations if capital raised through equity and/or debt financing is not sufficient for the Company to achieve its objectives.

 

  8  

 

 

Convertible Debt and Embedded Derivatives

 

Convertible debt is accounted for under the guidelines established by Accounting Standards Codification (“ASC”) 470-20, Debt with Conversion and Other Options. ASC 470-20 governs the calculation of an embedded beneficial conversion, a derivative instrument, which is treated as an additional discount to the instruments where derivative accounting does not apply. This applies during the period for which embedded conversion features are either fixed, contingently convertible, or cash or net settlement is in control of the Company. When equity instruments, such as warrants, are issued with convertible debt, the net proceeds from the transaction are allocated to the convertible debt and equity instruments based on their relative fair values. The proceeds allocated to the equity instruments may reduce the carrying value of the convertible debt, and such discount is amortized to interest expense over the term of the debt. The amount of the warrants and beneficial conversion feature will reduce the carrying value of the debt instrument to zero, but no further. The discount relating to the initial recording of the original issue discounts, issue costs, warrants and beneficial conversion feature are accreted, together with the premium, over the estimated term of the debt.

 

The excess of fair value of the embedded conversion feature, together with the original issue discounts, warrants, and issue costs over the face value of the debt, is recorded as an immediate charge in the accompanying statements of operations and cash flows. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations.

 

Basic and Diluted Net Loss per Common Share

 

Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the reporting period. The weighted average number of shares is calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. Diluted earnings per share reflects the potential dilution that could occur if stock options, warrants, and other commitments to issue common stock were exercised or equity awards vest, resulting in the issuance of common stock that could share in the earnings of the Company.

 

Diluted loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential common stock equivalents would be anti-dilutive as a result of the net loss.

 

Research and Development and Software Development Costs

 

Capitalization of certain software development costs are recorded after the determination of technological feasibility. Based on our product development process, technological feasibility is determined upon the completion of a working model. To date, costs incurred by us from the completion of the working model to the point at which the product is ready for general release do not have technological feasibility. Accordingly, we have charged all such costs to research and development expense in the period incurred. Research and development costs were $210,126 and $576,114 for the three and nine months ended June 30, 2018, respectively, and $198,004 and $954,499 for the three and nine months ended June 30, 2017, respectively.

 

Recent Accounting Announcements

 

The Financial Accounting Standards Board (“FASB”) issues Accounting Standards Updates (“ASU”) to amend the authoritative literature in the ASC. There have been a number of ASUs to date that amend the original text of the ASC. The Company believes those updates issued-to-date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company, or (iv) are not expected to have a significant impact on the Company.

 

  9  

 

 

NOTE 4 – CONVERTIBLE NOTES PAYABLE

 

FirstFire Global Opportunities Fund, LLC

 

On September 26, 2017, the Company issued a convertible note to FirstFire Global Opportunities Fund, LLC (“FirstFire”) with a principal amount of $330,000, which includes an original issue discount of $30,000. The Company incurred $8,500 in direct costs. The note accrued interest at 5% per annum and was to mature on March 26, 2018, six months following the issuance date. The note was convertible at $2.00 per share, subject to adjustment. The Company issued 50,000 shares of its common stock, as well as warrants to purchase an additional 165,000 shares of common stock at $4.50 per share with a term of two years. The note was amended on December 20, 2017, which reduced the conversion price of the note to $1.00 per share, subject to adjustment, reduced the exercise price of the warrants from $4.50 to $2.00, and required the Company to issue an additional 87,500 shares of common stock to FirstFire, which resulted in an extinguishment loss.

 

The Company accounted for the amendment of the FirstFire note using derivative accounting and recognized a loss on extinguishment of $358,038 during the three months ended December 31, 2017. The Company also recognized a derivative liability of $320,312 as of the note’s amendment date. The Company valued the derivative liability with the Black-Scholes valuation model on the date of the amendment using an expected life of one (1) year, volatility of 150%, and risk-free rate of 1.87%.

 

During the three and nine months ended June 30, 2018, the Company recognized a gain of $0 and $11,234, respectively, related to the change in fair value of the FirstFire derivative liability. The Company valued the derivative liability with the Black-Scholes valuation model as of March 21, 2018, immediately prior to the settlement of the note as described below, using an expected life of 0.78 years, volatility of 150%, and risk-free rate of 1.71%.

 

Upon amendment of the FirstFire note, the Company recorded a debt discount of $330,000. The Company amortized $0 and $312,813 of the debt discount to interest expense during the three and nine months ended June 30, 2018, respectively. Total interest expense related to the FirstFire note, including the debt discount amortization prior to the amendment, was $0 and $453,700 for the three and nine months ended June 30, 2018, respectively.

 

On March 21, 2018, the Company entered into a settlement agreement with FirstFire under which FirstFire converted $77,500 of the note payable into 50,000 shares of common stock, and the Company paid $350,000 to satisfy the derivative liability of $309,078 and the note payable in full. In connection with the settlement of the FirstFire note, the Company recognized a gain on extinguishment of $194,391.

 

Peak One Opportunity Fund LP

 

On December 14, 2017, the Company issued a convertible note to Peak One Opportunity Fund LP (“Peak One”) with a principal amount of $300,000, which includes an original issue discount of $30,000. The Company incurred $27,400 in direct costs. The note was to mature three years from the issuance date and provides the holder with the right to convert all or a portion of the outstanding principal balance to shares of the Company’s common stock at a conversion price of $1.00 per share, subject to certain adjustments to the conversion price under certain circumstances.

 

Together with the convertible note, the Company also issued 275,000 shares of its common stock, as well as warrants to purchase an additional 75,000 shares of common stock at $2.00 per share with a term of five years. The Company accounted for the convertible note to Peak One using derivative accounting and recognized a derivative liability of $267,750 as of the note’s issuance date. The Company valued the derivative liability with the Black-Scholes valuation model on the date of issuance using an expected life of 1.25 years, volatility of 150%, and risk-free rate of 1.82%. The Company also recognized a loss of $486,745 resulting from the excess fair value of the derivative in the convertible note and of the equity instruments issued with the convertible note.

 

During the three and nine months ended June 30, 2018, the Company recognized a loss of $1,794 and $19,770, respectively, related to the change in fair value of the Peak One derivative liability. The Company valued the derivative liability with the Black-Scholes valuation model as of April 30, 2018, immediately prior to the redemption of the note as described below, using an expected life of 1.17 years, volatility of 150%, and risk-free rate of 1.65%.

 

  10  

 

 

The Company recorded a debt discount of $300,000 upon issuance of the Peak One note. The Company amortized $8,197 and $37,432 of the debt discount to interest expense during the three and nine months ended June 30, 2018, respectively.

 

On April 30, 2018, the Company redeemed the Peak One note for $375,000 prior to the maturity date in accordance with the terms of the note. The Company also issued 71,429 shares of common stock with a fair value of $103,572. to Peak One. The Company recognized a loss on extinguishment of $153,621.

 

NOTE 5 - COMMITMENTS AND CONTINGENCIES

 

Terminated Employment Agreement with Former Chief Financial Officer

 

The Company previously had an employment agreement with its Chief Financial Officer (“CFO”), which terminated in 2015. There were amounts that were accrued and unpaid as of June 30, 2018 and September 30, 2017, totaling $376,512 and $338,437, respectively. According to the original agreement, the unpaid salaries were to accrue interest at 15%, which has been accrued at each reporting date. Related interest expense was $12,692 and $38,075 during the three and nine months ended June 30, 2018, respectively. Management believes that such amounts were previously satisfied through the issuance of common stock and does not intend to pay such amounts.

 

Employment Agreement with Chief Executive Officer

 

During the nine months ended June 30, 2018 and 2017, cash compensation to the Chief Executive Officer (“CEO”) amounted to $356,756 and $310,485, including benefits and $60,000 bonuses, respectively.

 

During the nine months ended June 30, 2018 and 2017, stock-based compensation for the CEO amounted to $0 and $1,629,000, respectively.

 

Litigation

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. A disgruntled former contracted consultant has brought an action in the Texas State court against the CEO and the Company alleging fraud and misrepresentation pertaining to stock and payments, all of which have been paid, and all stock has been delivered to him. He has also included a claim of partial ownership of some of the Company’s patent which is without merit in that any interest he may have had has been assigned to the Company. The claim is frivolous and without merit. The case is being vigorously defended on our behalf by our insurance carrier.

 

NOTE 6 - STOCKHOLDERS’ DEFICIT

 

As of June 30, 2018, the Company was authorized to issue 650,000,000 common shares and 10,000,000 preferred shares at a par value of $0.01.

 

Common Stock

 

Management determines the fair value of stock issuances using the closing stock price on the grant date.

 

Under the Company’s active Private Placement Memorandum, the Company issues Units, each consisting of one share of common stock and one warrant to purchase one additional share of common stock for $1.20 within five years. Additionally, the Company pays a 12.5% commission to the Paulson Investment Company.

 

During the three months ended June 30, 2018, there were 10,094,400 Units sold for $8,832,600, net of $1,261,800 in offering costs. During the nine months ended June 30, 2018, there were 11,407,400 Units sold for $10,009,925, net of $1,469,475 in offering costs. As of June 30, 2018, the Company had private placement deposits totaling $2,262,000, for which the related shares have not yet been authorized. As such, this amount was included in common stock subscription deposit as of June 30, 2018. The related offering costs of $282,750 were included in deferred offering costs as of June 30, 2018.

 

During the three months ended June 30, 2018, the Company issued 24,697 shares of common stock with a fair value of $37,045 to its employees as part of their compensation. During the nine months ended June 30, 2018, the Company issued 113,151 shares of common stock with a fair value of $204,788 to its employees as part of their compensation.

 

During the nine months ended June 30, 2018, the Company issued 50,000 shares of common stock with a fair value of $81,000 to settle a legal matter by two shareholders who claimed that they were entitled to 125,000 shares of common stock because of funds allegedly paid to the Company and promises allegedly made by the Company. The Company denied these allegations and settled the matter for 50,000 shares of common stock.

 

  11  

 

 

During the three months ended June 30, 2018, the Company issued 10,000 shares of common stock with a fair value of $15,000 to Magnolia Investor Relations for services rendered.

 

Preferred Stock

 

The Company’s Series A Preferred Stock is convertible into the Company’s common stock at a rate of one (1) preferred share to 1.5 common shares. Each share of the Preferred Stock has 1.5 votes on all matters presented to be voted by the holders of common stock. The holders of the Series A Preferred Stock can only convert the shares if agreed to by the Board of Directors.

 

As of June 30, 2018 and September 30, 2017, the Company had 1,000,000 and 10,000,000 shares, respectively, of preferred stock outstanding, which are convertible into common stock at a rate of 1 preferred share to 1.5 common shares. See Note 7 below.

 

NOTE 7 – RELATED PARTY TRANSACTIONS

 

In February 2018, the Company’s Chief Executive Officer converted his 9,000,000 shares of preferred stock into 13,500,000 shares of common stock.

 

NOTE 8 – SUBSEQUENT EVENTS

 

Subsequent to June 30, 2018, there were 5,924,600 Units sold for net proceeds of $5,466,775.

 

In July 2018, the Company entered into a new lease agreement for office space in Scottsdale, Arizona. The lease has a term of three years and monthly lease payments ranging from $1,608 to $1,705.

 

There have been no other reportable events that have occurred after June 30, 2018.

 

  12  

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

In this Quarterly Report, “Company,” “our company,” “us,” and “our” refer to Cipherloc Corporation and its subsidiaries, unless the context requires otherwise

 

Forward-Looking Statements

 

The following information contains certain forward-looking statements. Forward-looking statements are statements that estimate the happening of future events and are not based on historical fact. Forward-looking statements may be identified by the use of forward-looking terminology, such as “may,” “could,” “expect,” “estimate,” “anticipate,” “plan,” “predict,” “probable,” “possible,” “should,” “continue,” or similar terms, variations of those terms or the negative of those terms. The forward-looking statements specified in the following information have been compiled by our management on the basis of assumptions made by management and considered by management to be reasonable. Our future operating results, however, are impossible to predict and no representation, guaranty, or warranty is to be inferred from those forward-looking statements.

 

Our Business

 

Cipherloc Corporation is a technology and services solutions company for the rapidly expanding cloud-based cyber security industry. Cipherloc is based in Buda, Texas.

 

The Company has introduced an innovative and revolutionary new type of encryption technology with five international patents and two US patents pending and is the industry’s first “Polymorphic Cipher Engine”, called CipherLoc®. It is the first secure commercially viable advanced “Polymorphic Key Progression Algorithmic Cipher Engine” (PKPA). This morphing cipher can be used in any commercial data security industry and/or in sensitive applications.

 

The Company’s initial products are focused on protecting “data in motion” and will consist of three different offerings: CipherLoc EDGE (for mobile platforms), CipherLoc ENTERPRISE (for desktops, laptops, and tablets), and CipherLoc GATEWAY (for servers). Summaries for each of these products can be found on the Company’s website. The end goal with the release of these products is to offer end-to-end data security (i.e., data can be securely sent to/from any mobile device, any PC, and any server).

 

With a business-to-business model, the Company will directly pursue businesses that will embed Cipherloc’s technology within their own product offering. We will be offering these potential clients a fairly standard software licensing-maintenance model, under which they will license our software for use within their own products. Any company today that is currently using encryption technology becomes a potential customer for us. By targeting companies who are already building solutions that have encryption built-in to their products, we are planning to achieve scale much faster.

 

In June 2018, the Company hired a Vice President of Sales and Marketing to oversee the Company’s sales and business development.

 

Financial Results and Trends

 

Results of Operations for the Nine Months Ended June 30, 2018 and 2017

 

Revenue decreased to $316,248 from $351,633 for the nine months ended June 30, 2018 and 2017, respectively. Revenue decreased as a result of ratably recognizing a software license sale during the nine months ended June 30, 2018. The software license sale was recognized ratably through its expiration on June 10, 2018.

 

Cost of revenue decreased slightly to $89,230 from $90,900 for the nine months ended June 30, 2018 and 2017, respectively. Cost of revenue is comprised of salaries and maintenance costs related to the Company’s core Cipherloc products.

 

  13  

 

 

General and administrative expenses decreased to $838,988 from $2,956,596 for the nine months ended June 30, 2018 and 2017, respectively. General and administrative expenses decreased as a result of lower stock-based compensation.

 

Sales and marketing expenses decreased to $119,433 from $188,950 for the nine months ended June 30, 2018 and 2017, respectively. Sales and marketing expenses decreased as a result of lower stock-based compensation.

 

Research and development costs decreased to $576,114 from $954,499 for the nine months ended June 30, 2018 and 2017, respectively. Research and development costs decreased as a result of stock-based compensation and lower salaries.

 

Settlement expense decreased to $81,000 from $106,250 for the nine months ended June 30, 2018 and 2017, respectively. Settlement expense for the nine months ended June 30, 2018 resulted from the issuance of 50,000 shares of common stock to settle a legal claim. Settlement expense for the nine months ended June 30, 2017 resulted from the issuance of 25,000 shares of common stock for a software termination settlement.

 

Interest expense increased to $529,205 from $34,488 for the nine months ended June 30, 2018 and 2017, respectively. Interest expense increased due to interest incurred on the Company’s convertible notes payable.

 

Liquidity and Capital Resources

 

We have an accumulated deficit at June 30, 2018 of $52,932,001. We expect to incur substantial expenses and generate continued operating losses until we generate revenues sufficient to meet our obligations. At June 30, 2018, the Company had cash of $10,230,369. We believe that our existing cash balances are insufficient to fund future operations for the next 12 months. These factors raise doubt about the Company’s ability to continue as a going concern.

 

We depend upon the continued participation of our active PPM to finance our operations and need to obtain additional funding sources to explore potential strategic relationships and to provide capital and other resources for the further development and marketing of our products and business. During the nine months ended June 30, 2018, the Company has raised money in the form of a private placement of Units totaling $10,009,925.

 

There is no assurance that such funding, if required, will be available to us or, if available, will be available upon terms favorable to us. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Cash Flow

 

The following table summarizes, for the periods indicated, selected items in our condensed Statements of Cash Flows:

 

    Nine Months Ended  
    June 30,  
    2018     2017  
Net cash (used in) provided by:                
Operating activities   $ (1,503,802 )   $ (1,406,676 )
Investing activities   $     $ (2,798 )
Financing activities   $ 11,506,775     $ 1,186,720  

 

Operating Activities

 

Cash used in operating activities was $1,503,802 and $1,406,676 for the nine months ended June 30, 2018 and 2017, respectively. The change in cash used in operating activities was primarily due to changes in working capital usage.

 

  14  

 

 

Investing Activities

 

Cash used in investing activities was $0 and $2,798 for the nine months ended June 30, 2018 and 2017, respectively. The decrease in cash used in investing activities is related to a decrease in deposits held to secure leases and contracts.

 

Financing Activities

 

Cash provided by financing activities was $11,506,775 and $1,186,720 for the nine months ended June 30, 2018 and 2017, respectively. The increase in cash provided by financing activities was primarily due to more issuances of Units for cash.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements, including arrangements that would affect the liquidity, capital resources, market risk support, and credit risk support or other benefits.

 

WHERE YOU CAN FIND MORE INFORMATION

 

You are advised to read this Quarterly Report on Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

 

  15  

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We had no material changes in market risk from those described in “Part II, Item 7A — Quantitative and Qualitative Disclosures about Market Risk” of our Annual Report on Form 10-K for the year ended September 30, 2017.

 

ITEM 4. CONTROLS AND PROCEDURES

 

This report includes the certification of our Chief Executive Officer required by Rule 13a-14 of the Securities Exchange Act of 1934 (the “Exchange Act”). See Exhibits 31.1 and 31.2. This Item 4 includes information concerning the controls and control evaluations revered to in those certifications.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (the “SEC”) rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives.

 

As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer need to carry out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2018 due to 1) no formal evaluation has been performed by us and 2) the existence of the material weaknesses in internal control over financial reporting described below (which we view as an integral part of our disclosure controls and procedures). Based on the performance of additional procedures designed to ensure the reliability of our financial reporting, we believe that the financial statements included in this Quarterly Report fairly present, in all material respects, our financial position, results of operations and cash flows as of the dates, and for the periods, presented, in conformity with U.S. GAAP.

 

Management’s Report on Internal Control over Financial Reporting

 

Our Chief Executive Officer and the Chief Financial Officer are responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of our internal control over financial reporting. Internal control over financial reporting (as defined in Rules 13a-15(f) and 15d(f) under the Exchange Act) is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. GAAP. Internal control over financial reporting includes those policies and procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets, (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (c) provide reasonable assurance that receipts and expenditures are being made only in accordance with appropriate authorization of management and the Board of Directors, and (d) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.

 

In connection with the preparation of our Annual Report on Form 10-K for the year ended September 30, 2017, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our internal control over financial reporting as of September 30, 2017, and concluded that we did not maintain effective internal control over financial reporting as of September 30, 2017 due to the identification of material weaknesses. These material weaknesses remain as of June 30, 2018.

 

  16  

 

 

Management identified a number of deficiencies in the design and operating effectiveness of the Company’s internal controls as of September 30, 2017 that represent material weaknesses in our internal control over financial reporting. These deficiencies are the result of management’s failure to design, implement and maintain adequate operational and internal controls and processes, including a lack of sufficient accounting staff which resulted in inadequate segregation of duties, the inability to prove delivery of software, an insufficient number of personnel familiar with financial and SEC reporting requirements, inadequate monitoring and review controls over financial reporting and disclosures as well as transaction processing, and insufficient written policies and procedures for accounting and financial reporting.

 

Remediation Plan

 

Management has executed a remediation plan intended to address the material weaknesses discussed above. These remediation efforts are focused on:

 

  Additional accounting staff to provide adequate segregation of duties;
     
  Enhancing controls around proving the delivery of software;
     
  Retaining appropriate resources familiar with financial and SEC reporting requirements;
     
  Monitoring and reviewing controls over financial reporting and disclosures as well as transaction processing; and
     
  Enhancing and maintaining written policies and procedures for accounting and financial reporting.

 

During the three months ended June 30, 2018, management engaged additional resources to support the remediation efforts outlined above. In addition, management has continued to train key accounting staff to improve controls that will ultimately eliminate the material weaknesses discussed above, as well as improve the accounting and financial reporting process.

 

We expect that remediation, including testing of related controls, will be completed by the end of fiscal 2018.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2018 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting, other than the remediation actions discussed above.

 

Inherent Limitations on Internal Controls

 

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the control system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Limitations inherent in any control system include the following:

 

  Judgments in decision-making can be faulty, and control and process breakdowns can occur because of simple errors or mistakes;
     
  Controls can be circumvented by individuals, acting alone or in collusion with others, or by management override;
     
  The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions;
     
  Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with associated policies or procedures; and
     
  The design of a control system must reflect the fact that resources are constrained, and the benefits of controls must be considered relative to their costs.

 

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

  17  

 

 

PART II

OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

See Litigation in Note 6 – Commitments and Contingencies of the Notes to the Financial Statements in Part 1, Item 1 of this document.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS SECURITIES

 

The Company has unregistered sales of securities through an active PPM. During the three months ending June 30, 2018, through the utilization of a Private Placement Memorandum and upon receipt of executed Subscription Agreements, the Company sold and issued 10,094,400 Units for $8,832,600 in net cash proceeds pursuant to the exemption from the registration provisions of the Securities Act of 1933, as amended (the “Act”), afforded by Rule 506 of Regulation D.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

There were no defaults upon senior securities during the three months ended June 30, 2018.

 

ITEM 4. MINING SAFETY DISCLOSURES

 

N/A

 

ITEM 5. OTHER INFORMATION

 

There is no information with respect to which information is not otherwise called for by this form.

 

ITEM 6. EXHIBITS

 

Exhibits

 

3.1   Articles of Incorporation Incorporated by reference to the Registrant’s Form 10-SB filed on or about January 3, 2000.
3.2   Bylaws Incorporated by reference to the Registrant’s Form 10-QSB for the quarter ended December 31, 2000 and filed on or about February 14, 2001.
3.3   Amendment to the Articles of Incorporation indicating name change and reverse stock split as set out in Registrant’s Form 8-K dated and filed on March 23, 2015
4.1   S-8 Registration Filed on June 2, 2014 and by reference incorporated herein
4.2   S-8 Registration Filed on October 27, 2016 and by reference incorporated herein
5.1   Legal opinion of Carl P. Ranno included in the S-8 Registration filed on June 2, 2014
5.2   Legal opinion of Carl P. Ranno included in the S-8 Registration filed on October 27, 2016
10.1   Employment Agreement between National Scientific Corporation and Michael A. Grollman dated January 2001 Incorporated by reference to the Registrant’s Form 10-QSB for the quarter ended March 31, 2001 and filed on or about May 15, 2001.
10.2   Employment Agreement between National Scientific Corporation and Graham L. Clark dated January 2003 Incorporated by reference to the Registrant’s Form 10-QSB for the quarter ended June 30, 2004 and filed on or about August 16, 2004.
10.3   NSC Consulting Agreement dated August 2001, and Amendments dated August 2002 and July 2003, with Dr. El-Badawy El-Sharawy Incorporated by reference to the Registrant’s Form 10-QSB for the quarter ended June 30, 2004 and filed on or about August 16, 2004.
10.4   Amended and Restated 2000 Stock Option Plan Incorporated by reference to the Registrant’s Form 10-KSB for the year ended September 30, 2000 and filed on or about December 19, 2000.
10.5   Form of 2004 Stock Retainage Plan Agreement Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.6   Agreement Regarding Management Consulting Services with Stanton Walker of New York dated May 2003 Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.7  

Agreement Regarding Distribution and Marketing of Gotcha!® Child Safety Product and other products dated December 2002 with FutureCom Global, Inc. Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.

 

  18  

 

 

10.8   Purchase Order from Verify Systems, Inc., dated March 2003 for IBUSTM School Child Tracking Systems. Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.9   Letter of Understanding and Agreement dated April 2004 Regarding Sales and Distribution of Verify School safety products, and an Unlimited Software License with Anthony Grosso and CIS Services, LLC . Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.10     Letter of Intent from Positus, Inc. dba Bike & Cycle Trak, dated February 2003 for Design of Power Sports Tracking System. Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.11   Purchase Order from Positus, Inc. dba Bike & Cycle Trak, for Design of Power Sports Tracking System dated March 2003.  Incorporated by reference to the Registrant’s Form SB-2 filed on or around June 24, 2004.
10.12   Employment agreement of Michael De La Garza. Incorporated by reference to the Registrant’s Form 10-K for the year ended September 30, 2011 and filed on October 10, 2013
10.13   Employment Agreement of Pamela Thompson Incorporated by reference to the Registrant’s Form 10-K for the year ended September 30, 2011 and filed on October 10, 2013.
10.14   Licensing Agreement of Code Robert, LLC and Sunset Angel Productions, LLC. Incorporated by reference to the Registrant’s Form 8-K filed on April 25, 2015.
10.15   Employment Agreement of Dr. Albert Carlson, incorporated by reference to Form 8-K filed on September 4, 2015
10.16   Asset Purchase Agreement and Promissory Note re sale of MD Software dated September 29, 2015 . Incorporated by reference to the Registrant’s Form 10-K for the year ended September 30, 2015 and filed on February 2, 2016.
10.17   Asset Purchase Agreement with Isaiah Eichen dated October 22, 2015, incorporated by reference to the Registrant’s Form 10-Q for the quarter ending December 31, 2015 and filed on February 22, 2016.
10.18   Sisco Product Development Agreement dated November 6, 2015, incorporated by reference  to the Registrant’s Form 10-Q for the quarter ending December 31, 2015 and filed on February 22, 2016.
10.19   Cloud Medical Doctors Software Corporation 48-month Licensing Agreement with Gawk dated June 11, 2014, incorporated by reference to the Registrant’s Form 10-Q for the quarter ending December 31, 2015 and filed on February 22, 2016.
10.20   Employment agreement of Patrick Doherty dated January 16, 2016, incorporated by reference to the Registrant’s Form 10-Q for the quarter ending March 30, 2016 and filed on June 6, 2016.
10.21   Employment agreement of Carlos Gonzales dated March 14, 2016, incorporated by reference to the Registrant’s Form 10-Q for the quarter ending March 30, 2016 and filed on June 6, 2016.
10.22   Employment agreement of Mike Salas dated April 25, 2016, incorporated by reference to the Registrant’s Form 10-Q for the quarter ending June 30, 2016 and filed on September 2, 2016.
10.23   Lease agreement effective March 16, 2016 and addendum dated April 14, 2016, incorporated by reference  to the Registrant’s Form 10-Q for the quarter ending June 30, 2016 and filed on September 2, 2016.
10.24   Employment agreement of Mike Hufnagel dated June 7, 2016, incorporated by reference  to the Registrant’s Form 10-Q for the quarter ending June 30, 2016.
10.25   Software Licensing Agreement with GoSecured Dated August 29, 2016, incorporated by reference to the Registrant’s Form 10-K for the year ending September 30, 2017 and filed on February 2, 2017.
10.26   Consulting Agreement with Susan Hufnagel dated March 28, 2027 and incorporated herein
10.27   Employment agreement of Mike Hufnagel dated October 31, 2017 appointing him as Chief Operating Officer, incorporated by reference to the Registrant’s Form 8-K filed on October 31, 2017
10.28   Employment Agreement of Dr. Milton Mattox date June 25, 2018 appointing him as Vice President of Sales and Marketing incorporated by reference to the Registrant’s Form 8-K filed on June 27, 2018.
10.29   Lease agreement effective July 15, 2018 for property in Scottsdale, AZ , incorporated herein
16.1   Letter of GBH CPA, PC regarding change in Independent Registered Public Accounting firm dated April 7, 2015, incorporated by reference to the Registrant’s Form 8-K filed on April 10, 2015.
16.2   Letter of MaloneBailey,LLP, regarding change in Independent Registered Public Accounting firm dated April 22, 2016, incorporated by reference to the Registrant’s Form 8-K filed on April 25, 2016.
17.1   Letter of Resignation as Officer and Director dated December 30, 2014, incorporated by reference to the Registrant’s Form 8-K filed on January 2, 2015.
17.2   Appointment of two Directors one of which is also appointed as Chief Financial Officer on January 7, 2015 as incorporated by reference to the Registrant’s Form 8-K filed on January 8, 2015.
14   Code of Ethics Incorporated by reference to the Registrant’s Form 10QSB for the quarter ending June 30, 2004 filed on or around August 16, 2004.
31.1   Certification of Chief Executive Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of Chief Financial Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

  19  

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant Cipherloc Corporation
     
Date: August 14, 2018 By: /s/ Michael De La Garza
    Michael De La Garza
    Chairman, Chief Executive Officer (Principal Executive Officer), President

 

  20  

 

 

Cipherloc (QB) (USOTC:CLOK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cipherloc (QB) Charts.
Cipherloc (QB) (USOTC:CLOK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cipherloc (QB) Charts.